Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Plant Breeding and Biotechnology

Plant Breeding and Biotechnology

Crop cultivation has a long history in human civilization, with records showing the cultivation of cereal plants beginning at around 8000 BC. This early plant breeding was developed primarily to provide a steady supply of food.

Synthetic Biology

Synthetic Biology

Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...

Upstream Processing

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...

The Central Dogma

The Central Dogma

The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...

Recombinant DNA

Recombinant DNA

Recombinant DNA

Recombinant DNA

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

From bench to business: career opportunities in biotechnology.

Nature biotechnology·1997

Same author

The changing dynamics of strategic alliances between US biotechnology firms and Japanese corporations and universities.

Trends in biotechnology·1994

Same author

Finding what you need to know in the biotechnology business.

Trends in biotechnology·1994

Same author

Blood brothers. Alliances between biotechnology and pharmaceutical companies in the U.S.

Bio/technology (Nature Publishing Company)·1993

Same author

Away from home: U.S. sites of European and Japanese biotech R&D.

Bio/technology (Nature Publishing Company)·1992

Same author

Tracking trends in U.S. biotechnology.

Bio/technology (Nature Publishing Company)·1991

Search research articles

Related Experiment Video

Updated: Jul 11, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Biotechnology in europe.

Science (New York, N.Y.)

|June 13, 1986

Summary

This summary is machine-generated.

European Economic Community nations are boosting biotechnology commercialization, matching U.S. company numbers and government spending. Europe prioritizes industry-university links over basic research, differing from U.S. strategies.

More Related Videos

The MultiBac Protein Complex Production Platform at the EMBL

The MultiBac Protein Complex Production Platform at the EMBL

Published on: July 11, 2013

Operating and Biocontainment Procedures of a Facility for Laboratory Mice with a Natural Microbiome: Immunophenotyping Procedure

Operating and Biocontainment Procedures of a Facility for Laboratory Mice with a Natural Microbiome: Immunophenotyping Procedure

Published on: December 13, 2024

Related Experiment Videos

Last Updated: Jul 11, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

The MultiBac Protein Complex Production Platform at the EMBL

The MultiBac Protein Complex Production Platform at the EMBL

Published on: July 11, 2013

Operating and Biocontainment Procedures of a Facility for Laboratory Mice with a Natural Microbiome: Immunophenotyping Procedure

Operating and Biocontainment Procedures of a Facility for Laboratory Mice with a Natural Microbiome: Immunophenotyping Procedure

Published on: December 13, 2024

Area of Science:

Biotechnology commercialization strategies
Comparative analysis of biotechnology sectors

Background:

European Economic Community (EEC) nations have intensified efforts in biotechnology commercialization.
EEC biotechnology initiatives rival U.S. in company numbers and government investment.
Significant overlap exists between European and U.S. biotechnology operations and investments.

Purpose of the Study:

To examine and compare biotechnology commercialization strategies and efforts within EEC countries and the United States.
To highlight key differences in government emphasis between European and U.S. biotechnology development.

Main Methods:

Comparative analysis of government spending and company involvement in biotechnology.
Examination of industry-university collaboration and industrial project support.
Assessment of the extent of U.S. operations by European companies and vice versa.

Main Results:

European biotechnology efforts are comparable to U.S. efforts in scale (companies and funding).
European governments place greater emphasis on supporting industry-university collaborations and industrial projects.
The U.S. focuses more on the support of basic research in biotechnology.

Conclusions:

European biotechnology commercialization is a significant and growing sector, comparable to the U.S.
Divergent government support strategies may influence the trajectory of biotechnology development in Europe versus the U.S.
The interconnectedness of European and U.S. biotechnology markets necessitates a holistic view of global biotechnology trends.